VIDARABINE: 35 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
35
Total FAERS Reports
7 (20.0%)
Deaths Reported
25
Hospitalizations
35
As Primary/Secondary Suspect
14
Life-Threatening
2
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
FDA Application: 050486 ·
First Report: 20130808 · Latest Report: 20220507
What Are the Most Common VIDARABINE Side Effects?
#1 Most Reported
Toxic encephalopathy
6 reports (17.1%)
#2 Most Reported
Herpes zoster
5 reports (14.3%)
#3 Most Reported
Altered state of consciousness
4 reports (11.4%)
All VIDARABINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Toxic encephalopathy | 6 | 17.1% | 0 | 6 |
| Herpes zoster | 5 | 14.3% | 1 | 5 |
Who Reports VIDARABINE Side Effects? Age & Gender Data
Gender: 64.3% female, 35.7% male. Average age: 55.4 years. Most reports from: JP. View detailed demographics →
Is VIDARABINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2013 | 3 | 1 | 3 |
| 2014 | 2 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 0 |
| 2017 | 4 | 1 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 0 |
| 2022 | 1 | 0 | 1 |
What Is VIDARABINE Used For?
| Indication | Reports |
|---|---|
| Herpes zoster | 8 |
| Acute lymphocytic leukaemia recurrent | 5 |
Official FDA Label for VIDARABINE
Official prescribing information from the FDA-approved drug label.